Barbexaclone Explained

Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine.^[1] It was introduced in 1965. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results"^[2] had not yet been confirmed nor denied in controlled trials.

Potency

100 mg of barbexaclone is equivalent to 60 mg of phenobarbital.

Further reading

• Book: The Treatment of Epilepsy . 2nd . Shorvon SR, Fish DR, Perucca E, Dodson WE . Published by Blackwell . 2004 . 472 . 0-632-06046-8 .

Notes and References

1. Book: Shorvon S, Perucca E, Engel Jr J . The Treatment of Epilepsy . 23 September 2015 . Wiley . 978-1-118-93699-3 . 1706–1707 .
2. Salles Barbosa MF . [Barbexaclone in the treatment of cerebral dysrhythmia] . Arquivos de Neuro-Psiquiatria . 36 . 3 . 245–249 . September 1978 . 28716 . 10.1590/s0004-282x1978000300009 . free .